ISRCTN11911344
Completed
未知
Efficacy of a text messaging service for patients with type 2 diabetes to support basal insulin titration
Roche Diabetes Care GmbH0 sites30 target enrollmentAugust 14, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Roche Diabetes Care GmbH
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Signed written informed consent
- •2\. Male and female patients with at least 21 years of age
- •3\. Diabetes mellitus type 2
- •4\. Initiation of BOT planned including training in diabetes mellitus, BOT therapy, FBG measurement and basal insulin administration
- •5\. Individual FBG target range set to 140 mg/dL (7\.8 mmol/l) or lower by the investigator as described by BOT guidelines
- •6\. HbA1c \=7\.5% (58,5 mmol/mol), determined within the previous 3 months
- •7\. Possessing and using a mobile phone including SMS messaging and having access to the mobile phone network while at home (self\-assessed)
- •8\. Ability and willingness to participate in the study, to read and understand all study materials (subject information, informed consent and data protection form, IFU, SMS text messages, questionnaires) and to comply with study procedures, including daily BG measurement with the Accu\-Chek® BG meter handed out for the study and administration of once\-daily, long\-acting insulin as well as timely sending and receiving SMS text messages in the morning and in the evening and blood draws for repeated HbA1c determination
Exclusion Criteria
- •1\. Prior insulin therapy except for gestational diabetes or for \< 1 week
- •2\. Current insulin therapy, e.g. prandial insulin, premixed insulin
- •3\. Known impaired awareness of hypoglycemia with current history of regular hypoglycemia or hospitalization(s) because of severe hypoglycemia in the previous 3 months
- •4\. Significant manifestation of severe diabetes\-related long\-term complications e.g. severe retinopathy, neuropathy, nephropathy requiring dialysis
- •5\. Pregnant or planning to become pregnant or breastfeeding
- •6\. Legal incompetence or limited legal competence
- •7\. Serious or unstable chronic physical or psychological condition rendering the subject unable to understand the nature and the scope of the study and to follow the study procedures
- •8\. Addiction to alcohol or other substance(s) of abuse as assessed by the investigator
- •9\. Dependency on sponsor or Investigator (e.g. co\-worker or family member)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
Messaging Service for Patients with Type 2 Diabetes to support Insulin TitratioHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/05/033506Roche Diabetes Care India Pvt Ltd
Completed
Not Applicable
The effectiveness of text message based health literacy on medication adherence in patients with type 2 diabetes mellitus: A randomized controlled trial.type 2 diabetes mellitusJPRN-UMIN000014747Department of Health Sciences, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Japan100
Not yet recruiting
Not Applicable
Impact Of Short Messaging Service (SMS)-Based Interventions on Medication Adherence Among Clinic Attendees at Risk of Stroke: A Randomized Controlled TrialCirculatory SystemNervous System DiseasesCardiologyPACTR202308767234235Daniel Ehis Aigbonoga150
Not yet recruiting
Not Applicable
Clinical Application of Text Messaging for Anxiety and DepressioAnxietyDepressionMental Health - AnxietyMental Health - DepressionACTRN12621000410853Australian Catholic University450
Completed
Not Applicable
YourCall Study: The effectiveness of text messaging to address hazardous drinking among trauma patientsHazardous alcohol useInjuriesInjuries and Accidents - Other injuries and accidentsPublic Health - Health promotion/educationACTRN12612001220853The University of Auckland570